Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants

Anna R. Mäkelä; Hasan Ugurlu; Liina Hannula; Ravi Kant; Petja Salminen; Riku Fagerlund; Sanna Mäki; Anu Haveri; Tomas Strandin; Lauri Kareinen; Jussi Hepojoki; Suvi Kuivanen; Lev Levanov; Arja Pasternack; Rauno A. Naves; Olli Ritvos; Pamela Österlund; Tarja Sironen; Olli Vapalahti; Anja Kipar; Juha T. Huiskonen; Ilona Rissanen; Kalle Saksela

doi:10.1038/s41467-023-37290-6

Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants

Anna R. Mäkelä, Hasan Ugurlu, Liina Hannula, Ravi Kant, Petja Salminen, Riku Fagerlund, Sanna Mäki, Anu Haveri, Tomas Strandin, Lauri Kareinen, Jussi Hepojoki, Suvi Kuivanen, Lev Levanov, Arja Pasternack, Rauno A. Naves, Olli Ritvos, Pamela Österlund, Tarja Sironen, Olli Vapalahti, Anja KiparJuha T. Huiskonen, Ilona Rissanen, Kalle Saksela

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Article number	1637
Journal	Nature Communications
Volume	14
Issue number	1
Number of pages	12
ISSN	2041-1723
DOIs	https://doi.org/10.1038/s41467-023-37290-6
Publication status	Published - 24 Mar 2023
MoE publication type	A1 Journal article-refereed

Fields of Science

3111 Biomedicine
11832 Microbiology and virology

Access to Document

10.1038/s41467-023-37290-6

s41467-023-37290-6Final published version, 3.75 MBLicence: CC BY

Cite this

Mäkelä, A. R., Ugurlu, H., Hannula, L., Kant, R., Salminen, P., Fagerlund, R., Mäki, S., Haveri, A., Strandin, T., Kareinen, L., Hepojoki, J., Kuivanen, S., Levanov, L., Pasternack, A., Naves, R. A., Ritvos, O., Österlund, P., Sironen, T., Vapalahti, O., ... Saksela, K. (2023). Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants. Nature Communications, 14(1), Article 1637. https://doi.org/10.1038/s41467-023-37290-6

@article{d150d633ec5a40bda444c3f4c5d8fc5e,

title = "Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants",

keywords = "Domain, 3111 Biomedicine, 11832 Microbiology and virology",

author = "M{\"a}kel{\"a}, {Anna R.} and Hasan Ugurlu and Liina Hannula and Ravi Kant and Petja Salminen and Riku Fagerlund and Sanna M{\"a}ki and Anu Haveri and Tomas Strandin and Lauri Kareinen and Jussi Hepojoki and Suvi Kuivanen and Lev Levanov and Arja Pasternack and Naves, {Rauno A.} and Olli Ritvos and Pamela {\"O}sterlund and Tarja Sironen and Olli Vapalahti and Anja Kipar and Huiskonen, {Juha T.} and Ilona Rissanen and Kalle Saksela",

year = "2023",

month = mar,

day = "24",

doi = "10.1038/s41467-023-37290-6",

language = "English",

volume = "14",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

number = "1",

}

Mäkelä, AR , Ugurlu, H , Hannula, L , Kant, R , Salminen, P , Fagerlund, R, Mäki, S, Haveri, A, Strandin, T , Kareinen, L , Hepojoki, J , Kuivanen, S , Levanov, L , Pasternack, A, Naves, RA, Ritvos, O, Österlund, P, Sironen, T , Vapalahti, O, Kipar, A, Huiskonen, JT , Rissanen, I & Saksela, K 2023, 'Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants', Nature Communications, vol. 14, no. 1, 1637. https://doi.org/10.1038/s41467-023-37290-6

TY - JOUR

T1 - Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants

AU - Mäkelä, Anna R.

AU - Ugurlu, Hasan

AU - Hannula, Liina

AU - Kant, Ravi

AU - Salminen, Petja

AU - Fagerlund, Riku

AU - Mäki, Sanna

AU - Haveri, Anu

AU - Strandin, Tomas

AU - Kareinen, Lauri

AU - Hepojoki, Jussi

AU - Kuivanen, Suvi

AU - Levanov, Lev

AU - Pasternack, Arja

AU - Naves, Rauno A.

AU - Ritvos, Olli

AU - Österlund, Pamela

AU - Sironen, Tarja

AU - Vapalahti, Olli

AU - Kipar, Anja

AU - Huiskonen, Juha T.

AU - Rissanen, Ilona

AU - Saksela, Kalle

PY - 2023/3/24

Y1 - 2023/3/24

KW - Domain

KW - 3111 Biomedicine

KW - 11832 Microbiology and virology

U2 - 10.1038/s41467-023-37290-6

DO - 10.1038/s41467-023-37290-6

M3 - Article

C2 - 36964125

SN - 2041-1723

VL - 14

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 1637

ER -